Greenberg PL, Stone RM, Al-Kali A, Bennett JM, Borate U, Brunner AM et al (2022) NCCN guidelines® insights: myelodysplastic syndromes, version 3.2022. J Natl Compr Canc Netw 20(2):106–117

Article  PubMed  Google Scholar 

Menssen AJ, Walter MJ (2020) Genetics of progression from MDS to secondary leukemia. Blood 136(1):50–60

Article  PubMed  PubMed Central  Google Scholar 

Fontana D, Elli EM, Pagni F, Piazza R (2023) Myelodysplastic syndromes/myeloproliferative overlap neoplasms and differential diagnosis in the WHO and ICC 2022 era: a focused review. Cancers 15(12):3175. https://doi.org/10.3390/cancers15123175

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang G, Fu B, Hu S, Lu X, Tang Z, Li S et al (2015) Prognostic impact of acquisition of cytogenetic abnormalities during the course of chronic myelomonocytic leukemia. Am J Hematol 90(10):882–887

Article  CAS  PubMed  Google Scholar 

Malcovati L, Papaemmanuil E, Bowen DT, Boultwood J, Della Porta MG, Pascutto C et al (2011) Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms. Blood 118(24):6239–6246

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hasserjian RP, Germing U, Malcovati L (2023) Diagnosis and classification of myelodysplastic syndromes. Blood 142(26):2247–2257

Article  CAS  PubMed  Google Scholar 

Makishima H, Yoshizato T, Yoshida K, Sekeres MA, Radivoyevitch T, Suzuki H et al (2017) Dynamics of clonal evolution in myelodysplastic syndromes. Nat Genet 49(2):204–212

Article  CAS  PubMed  Google Scholar 

da Silva-Coelho P, Kroeze LI, Yoshida K, Koorenhof-Scheele TN, Knops R, van de Locht LT et al (2017) Clonal evolution in myelodysplastic syndromes. Nat Commun 8:15099

Article  PubMed  PubMed Central  Google Scholar 

Pang Y, Chen X, Ji T, Cheng M, Wang R, Zhang C, Liu M, Zhang J, Zhong C (2023) The chromatin remodeler ATRX: role and mechanism in biology and cancer. Cancers 15(8):2228. https://doi.org/10.3390/cancers15082228

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schroeder MP, Bastian L, Eckert C, Gökbuget N, James AR, Tanchez JO et al (2019) Integrated analysis of relapsed B-cell precursor acute lymphoblastic leukemia identifies subtype-specific cytokine and metabolic signatures. Sci Rep 9(1):4188

Article  PubMed  PubMed Central  Google Scholar 

Garcia-Gimenez A, Ditcham JE, Azazi DMA, Giotopoulos G, Asby R, Meduri E et al (2025) CREBBP inactivation sensitizes B cell acute lymphoblastic leukemia to ferroptotic cell death upon BCL2 inhibition. Nat Commun 16(1):4274

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mullighan CG, Zhang J, Kasper LH, Lerach S, Payne-Turner D, Phillips LA et al (2011) CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature 471(7337):235–239

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rampotas A, Roddie C (2025) The present and future of CAR T-cell therapy for adult B-cell ALL. Blood 145(14):1485–97

Article  CAS  PubMed  Google Scholar 

Kantarjian H, Stein A, Gökbuget N, Fielding AK, Schuh AC, Ribera JM et al (2017) Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia. N Engl J Med 376(9):836–847

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yoda A, Adelmant G, Tamburini J, Chapuy B, Shindoh N, Yoda Y et al (2015) Mutations in G protein β subunits promote transformation and kinase inhibitor resistance. Nat Med 21(1):71–75

Article  CAS  PubMed  Google Scholar 

Zimmermannova O, Doktorova E, Stuchly J, Kanderova V, Kuzilkova D, Strnad H et al (2017) An activating mutation of GNB1 is associated with resistance to tyrosine kinase inhibitors in ETV6-ABL1-positive leukemia. Oncogene 36(43):5985–5994

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barton JC, Conrad ME, Parmley RT (1980) Acute lymphoblastic leukemia in idiopathic refractory sideroblastic anemia: evidence for a common lymphoid and myeloid progenitor cell. Am J Hematol 9(1):109–115

Article  CAS  PubMed  Google Scholar 

Hussein KK, Salem Z, Bottomley SS, Livingston RB (1982) Acute leukemia in idiopathic sideroblastic anemia: response to combination chemotherapy. Blood 59(3):652–656

Article  CAS  PubMed  Google Scholar 

Inoshita T (1985) Acute lymphoblastic leukemia following myelodysplastic syndrome. Am J Clin Pathol 84(2):233–237

Article  CAS  PubMed  Google Scholar 

Berneman ZN, Van Bockstaele D, De Meyer P, Van der Planken M, Vertessen F, De Bock R et al (1985) A myelodysplastic syndrome preceding acute lymphoblastic leukaemia. Br J Haematol 60(2):353–354

Article  CAS  PubMed  Google Scholar 

Pereira AM, de Tavares Castro J, Santos EG, Perloiro MC, Catovsky D (1985) T lymphoblastic transformation of refractory anaemia with excess of blasts. Clin Lab Haematol 7(1):89–95

Article  CAS  PubMed  Google Scholar 

Eridani S, Chan LC, Halil O, Pearson TC (1985) Acute biphenotypic leukaemia (myeloid and null-ALL type) supervening in a myelodysplastic syndrome. Br J Haematol 61(3):525–529

Article  CAS  PubMed  Google Scholar 

Ascensao JL, Kay NE, Wright JJ, Arthur D, Finkel B, Rydell R et al (1986) Lymphoblastic transformation of myelodysplastic syndrome. Am J Hematol 22(4):431–434

Article  CAS  PubMed  Google Scholar 

Bonati A, Delia D, Starcich R (1986) Progression of a myelodysplastic syndrome to pre-B acute lymphoblastic leukaemia with unusual phenotype. Br J Haematol 64(3):487–491

Article  CAS  PubMed  Google Scholar 

Nagler A, Brenner B, Tatarsky I (1986) Secondary refractory anemia with excess of blasts in transformation terminating as acute lymphoblastic leukemia. Acta Haematol 76(2–3):164–165

Article  CAS  PubMed  Google Scholar 

Stark AN, Scott CS, Bhatt B, Roberts BE (1986) Myelodysplastic syndrome coexisting with acute lymphoblastic leukaemia. J Clin Pathol 39(7):728–730

Article  CAS  PubMed  PubMed Central  Google Scholar 

Serke S, Stein H, Anagnostopoulos I, Schmidt C, Neubauer A, Siebert W et al (1989) Acute leukaemia with B- and T-lymphoid and myeloid characteristics in a patient with a myelodysplastic syndrome. Br J Haematol 72(1):110–111

Article  CAS  PubMed  Google Scholar 

Nakamura K, Inaba T, Nishimura J, Morgan GJ, Hayashi Y, Hanada R et al (1991) Molecular analysis of BCR/ABL products in a case of myelodysplastic syndrome with late appearing Philadelphia chromosome. Br J Haematol 78(1):130–132

Article  CAS  PubMed  Google Scholar 

Kouides PA, Bennett JM (1995) Transformation of chronic myelomonocytic leukemia to acute lymphoblastic leukemia: case report and review of the literature of lymphoblastic transformation of myelodysplastic syndrome. Am J Hematol 49(2):157–162

Article  CAS  PubMed  Google Scholar 

Abruzzese E, Buss D, Rainer R, Pettenati MJ, Rao PN (1996) Progression of a myelodysplastic syndrome to pre-B acute lymphoblastic leukemia: a case report and cell lineage study. Ann Hematol 73(1):35–38